Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-IT: rFVIIa for Spot-Sign Positive ICH
NCT00810888Phase 2Completed
- Sponsor
- University of Cincinnati
- Start
- Nov 2010
- Primary completion
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of coagulation factor VIIa in intracerebral hemorrhage (ICH), sponsored by University of Cincinnati. Started Nov 2010; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT00810888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810888.